Asthma: Chronopharmacotherapy and the molecular clock

Naoto Burioka, Yasushi Fukuoka, Satoru Koyanagi, Masanori Miyata, Miyako Takata, Hiroki Chikumi, Hiroshi Takane, Masanari Watanabe, Masahiro Endo, Takanori Sako, Hisashi Suyama, Shigehiro Ohdo, Eiji Shimizu

Research output: Contribution to journalReview article

41 Citations (Scopus)

Abstract

Bronchial asthma is characterized by chronic airways inflammation and reversible airflow limitation. In patients with asthma, symptoms generally worsen during the early hours of the morning, and pulmonary function often deteriorates at the same time, suggesting a role for chronopharmacotherapy. Several drugs for asthma have been developed based on chronopharmacology. Most medications employed for the chronotherapy of asthma are administered once at night with the goal of preventing chronic airway inflammation or development of airflow limitation. In addition to bronchodilators, the inhaled glucocorticosteroid ciclesonide is now available with once-daily dosing, which also improves patients' compliance. Numerous investigations have demonstrated the usefulness of chronotherapy for asthma, especially for patients with nocturnal asthma. This review focuses on chronotherapy of asthma, and also provides a molecular biological explanation for the influence of asthma medications on the clock genes.

Original languageEnglish
Pages (from-to)946-955
Number of pages10
JournalAdvanced Drug Delivery Reviews
Volume62
Issue number9-10
DOIs
Publication statusPublished - Jul 1 2010

Fingerprint

Asthma
Chronotherapy
Inflammation
Bronchodilator Agents
Patient Compliance
Lung
Pharmaceutical Preparations
Genes

All Science Journal Classification (ASJC) codes

  • Pharmaceutical Science

Cite this

Burioka, N., Fukuoka, Y., Koyanagi, S., Miyata, M., Takata, M., Chikumi, H., ... Shimizu, E. (2010). Asthma: Chronopharmacotherapy and the molecular clock. Advanced Drug Delivery Reviews, 62(9-10), 946-955. https://doi.org/10.1016/j.addr.2010.03.012

Asthma : Chronopharmacotherapy and the molecular clock. / Burioka, Naoto; Fukuoka, Yasushi; Koyanagi, Satoru; Miyata, Masanori; Takata, Miyako; Chikumi, Hiroki; Takane, Hiroshi; Watanabe, Masanari; Endo, Masahiro; Sako, Takanori; Suyama, Hisashi; Ohdo, Shigehiro; Shimizu, Eiji.

In: Advanced Drug Delivery Reviews, Vol. 62, No. 9-10, 01.07.2010, p. 946-955.

Research output: Contribution to journalReview article

Burioka, N, Fukuoka, Y, Koyanagi, S, Miyata, M, Takata, M, Chikumi, H, Takane, H, Watanabe, M, Endo, M, Sako, T, Suyama, H, Ohdo, S & Shimizu, E 2010, 'Asthma: Chronopharmacotherapy and the molecular clock', Advanced Drug Delivery Reviews, vol. 62, no. 9-10, pp. 946-955. https://doi.org/10.1016/j.addr.2010.03.012
Burioka N, Fukuoka Y, Koyanagi S, Miyata M, Takata M, Chikumi H et al. Asthma: Chronopharmacotherapy and the molecular clock. Advanced Drug Delivery Reviews. 2010 Jul 1;62(9-10):946-955. https://doi.org/10.1016/j.addr.2010.03.012
Burioka, Naoto ; Fukuoka, Yasushi ; Koyanagi, Satoru ; Miyata, Masanori ; Takata, Miyako ; Chikumi, Hiroki ; Takane, Hiroshi ; Watanabe, Masanari ; Endo, Masahiro ; Sako, Takanori ; Suyama, Hisashi ; Ohdo, Shigehiro ; Shimizu, Eiji. / Asthma : Chronopharmacotherapy and the molecular clock. In: Advanced Drug Delivery Reviews. 2010 ; Vol. 62, No. 9-10. pp. 946-955.
@article{c8bdcc7e5599445aae0206b3ae3e22ce,
title = "Asthma: Chronopharmacotherapy and the molecular clock",
abstract = "Bronchial asthma is characterized by chronic airways inflammation and reversible airflow limitation. In patients with asthma, symptoms generally worsen during the early hours of the morning, and pulmonary function often deteriorates at the same time, suggesting a role for chronopharmacotherapy. Several drugs for asthma have been developed based on chronopharmacology. Most medications employed for the chronotherapy of asthma are administered once at night with the goal of preventing chronic airway inflammation or development of airflow limitation. In addition to bronchodilators, the inhaled glucocorticosteroid ciclesonide is now available with once-daily dosing, which also improves patients' compliance. Numerous investigations have demonstrated the usefulness of chronotherapy for asthma, especially for patients with nocturnal asthma. This review focuses on chronotherapy of asthma, and also provides a molecular biological explanation for the influence of asthma medications on the clock genes.",
author = "Naoto Burioka and Yasushi Fukuoka and Satoru Koyanagi and Masanori Miyata and Miyako Takata and Hiroki Chikumi and Hiroshi Takane and Masanari Watanabe and Masahiro Endo and Takanori Sako and Hisashi Suyama and Shigehiro Ohdo and Eiji Shimizu",
year = "2010",
month = "7",
day = "1",
doi = "10.1016/j.addr.2010.03.012",
language = "English",
volume = "62",
pages = "946--955",
journal = "Advanced Drug Delivery Reviews",
issn = "0169-409X",
publisher = "Elsevier",
number = "9-10",

}

TY - JOUR

T1 - Asthma

T2 - Chronopharmacotherapy and the molecular clock

AU - Burioka, Naoto

AU - Fukuoka, Yasushi

AU - Koyanagi, Satoru

AU - Miyata, Masanori

AU - Takata, Miyako

AU - Chikumi, Hiroki

AU - Takane, Hiroshi

AU - Watanabe, Masanari

AU - Endo, Masahiro

AU - Sako, Takanori

AU - Suyama, Hisashi

AU - Ohdo, Shigehiro

AU - Shimizu, Eiji

PY - 2010/7/1

Y1 - 2010/7/1

N2 - Bronchial asthma is characterized by chronic airways inflammation and reversible airflow limitation. In patients with asthma, symptoms generally worsen during the early hours of the morning, and pulmonary function often deteriorates at the same time, suggesting a role for chronopharmacotherapy. Several drugs for asthma have been developed based on chronopharmacology. Most medications employed for the chronotherapy of asthma are administered once at night with the goal of preventing chronic airway inflammation or development of airflow limitation. In addition to bronchodilators, the inhaled glucocorticosteroid ciclesonide is now available with once-daily dosing, which also improves patients' compliance. Numerous investigations have demonstrated the usefulness of chronotherapy for asthma, especially for patients with nocturnal asthma. This review focuses on chronotherapy of asthma, and also provides a molecular biological explanation for the influence of asthma medications on the clock genes.

AB - Bronchial asthma is characterized by chronic airways inflammation and reversible airflow limitation. In patients with asthma, symptoms generally worsen during the early hours of the morning, and pulmonary function often deteriorates at the same time, suggesting a role for chronopharmacotherapy. Several drugs for asthma have been developed based on chronopharmacology. Most medications employed for the chronotherapy of asthma are administered once at night with the goal of preventing chronic airway inflammation or development of airflow limitation. In addition to bronchodilators, the inhaled glucocorticosteroid ciclesonide is now available with once-daily dosing, which also improves patients' compliance. Numerous investigations have demonstrated the usefulness of chronotherapy for asthma, especially for patients with nocturnal asthma. This review focuses on chronotherapy of asthma, and also provides a molecular biological explanation for the influence of asthma medications on the clock genes.

UR - http://www.scopus.com/inward/record.url?scp=77955859344&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955859344&partnerID=8YFLogxK

U2 - 10.1016/j.addr.2010.03.012

DO - 10.1016/j.addr.2010.03.012

M3 - Review article

C2 - 20359514

AN - SCOPUS:77955859344

VL - 62

SP - 946

EP - 955

JO - Advanced Drug Delivery Reviews

JF - Advanced Drug Delivery Reviews

SN - 0169-409X

IS - 9-10

ER -